Meet Dr. Marqueta Abraham
We were lucky to catch up with Dr. Marqueta Abraham DNP, APRN, PMHNP-BC recently and have shared our conversation below.
We were lucky to catch up with Dr. Marqueta Abraham DNP, APRN, PMHNP-BC recently and have shared our conversation below.
Most high school students would normally be sitting in class on a Friday morning, but Alex Knowles, a sophomore at Germantown High School, was experimenting with hand drills and bone saws.
Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists’ office.
Veralux, the state’s first dedicated whole-body MRI center, is set to open this month in the Pinnacle Hills area of Rogers.
Elyse Warren, a brilliant and driven senior at Millsaps College, has been named a finalist for the highly prestigious Rhodes Scholarship.
The University of Tennessee Health Science Center has been placed at the forefront of the critical global dialogue surrounding blockbuster obesity drugs like Ozempic and Wegovy with the publication of a commentary co-authored by Professor Liza Makowski, PhD, associate director for Education and Development in the Center for Cancer Research at UT Health Science Center.
As the obesity epidemic continues to affect the U.S. healthcare system, a new commentary discusses GLP-1 drugs, including Ozempic, Wegovy, and Zepbound, which have become widely used in obesity treatment.
Infants who demonstrate delays in multiple domains between 9 and 12 months are significantly more likely to still show persistent challenges at follow-up, according to findings from a large population-based study in Israel.